Board, committees and an organigram. How we are organized and who does what: learn more about us.
Oncode Institute operates with a small team to provide valorization services, general management and support to all the Oncode Researchers across the Partner Institutions. Oncode does not have its own research facilities or staff. Every Oncode Researcher is employed by one of the Partner Institutions, at which the actual research is conducted.
Oncode’s staff is guided and supported by its board and committees. The Oncode team and the members of the boards and committees perform their duties in awareness of their extraordinary responsibility to spend public monies in the most effective and efficient manner possible, to serve society and to set an example.
Oncode is founded on the assumption that everyone involved in the Institute is committed to constantly improving Oncode and its way of working. Oncode listens. Not only to its boards, committees and the Oncode team, but to all Oncode Researchers, partners and patients. Because all of us together know more than the few managing the Institute. If you have any questions or suggestions, please feel free to contact us at any time.
The members of the Managing Board operate and manage Oncode, taking into account that Oncode has an important social responsibility. The Managing Board consists of a General Director, Valorization Director and a Chief Scientific Officer.
Ton Rijnders has extensive experience in leading multidisciplinary organizations with individual experts and leading a portfolio of collaborations with public and private partners.
"Innovative cancer treatments can be realized only through a combination of individual excellence and collaborative development."
Angus Livingstone has played critical roles in the creation of many Canadian technology transfer and commercialisation initiatives. The enormous valorization potential grounded in The Netherlands’ excellent fundamental cancer research led him to cross the ocean to become Oncode’s Valorization Director.
"I am excited to bring to the Netherlands my 30 years of experience in translating academic research into social and economic benefits."
Oncode Investigator Geert Kops is Scientific Director and chair of the Research Management Committee of Oncode Institute. Geert Kops is group leader at the Hubrecht Institute and professor of Molecular Tumor Cell Biology at the University Medical Center Utrecht. His group studies the signaling networks that regulate chromosome segregation, the evolution of cell division processes and the role of chromosomal instability in cancer.
"Synergy between Oncode researchers will create even more breakthrough discoveries, also towards the clinic.”
To ensure good governance, Oncode has developed its Good Governance Charter based on the rules in the Dutch Corporate Governance Code and the Good Governance Code for charities (SBF-Code Goed Bestuur).
The Good Governance Charter constitutes the regulations of Oncode’s most prominent and influential boards and committees, and also comprehends key policies. Please find the Good Governance Charter here. Please note that the Good Governance Charter is still work in progress and will be finalized soon.
Oncode Institute is a foundation. Please find Oncode’s articles of association here.
Please find Oncode on the ANBI website.